Stoke Therapeutics (STOK) Shares Issued (2018 - 2026)
Stoke Therapeutics (STOK) recorded quarterly Shares Issued of $465000.0 in Q1 2026, down 93.88% quarter-over-quarter from $7.6 million in Q4 2025, and down 53.69% on a YoY basis from $1.0 million in Q1 2025.
Stoke Therapeutics (STOK) Shares Issued (2018 - 2026) Analysis & Trends
Stoke Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $465000.0 for Q1 2026.
- In Q1 2026, Shares Issued fell 53.69% year-over-year to $465000.0; the TTM figure through Mar 2026 stood at $8.1 million (up 215.25% YoY), while the FY2025 annual figure was $8.6 million, up 399.59% from the prior year.
- Shares Issued was $465000.0 for Q1 2026 at Stoke Therapeutics, down from $7.6 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $7.6 million in Q4 2025 to a low of -$556000.0 in Q3 2025.
- Historically, Shares Issued has averaged $700882.4 across 5 years, with a median of $168000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Shares Issued soared 1666.67% in 2024, then slumped 500.0% in 2025.
- A 5-year view of Shares Issued shows it stood at $118000.0 in 2022, then jumped by 59.32% to $188000.0 in 2023, then surged by 201.6% to $567000.0 in 2024, then soared by 1240.56% to $7.6 million in 2025, then sank by 93.88% to $465000.0 in 2026.
- The last three Shares Issued figures came in at $465000.0 (Q1 2026), $7.6 million (Q4 2025), and -$556000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Stoke Therapeutics | 1.95 Bn | 1.95 Bn | - | 465,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 465,000.00 |
| Mar 31, 2026 | 465,000.00 |
| Dec 31, 2025 | 7.60 Mn |
| Dec 31, 2025 | 7.60 Mn |
| Sep 30, 2025 | -556,000.00 |
| Sep 30, 2025 | -556,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 567,000.00 |
| Dec 31, 2024 | 567,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | 848,000.00 |
| Jun 30, 2024 | 848,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Dec 31, 2023 | 188,000.00 |